Intervention

Prostate biopsy

ClinicalTrials.gov intervention label

Clinical trials15

Recruiting2

Common conditions11

Lead sponsors shown14

Clinical trials

15 shown

Robot-Assisted Prostate Biopsy With a Novel Ultrasound ProbeNCT07271017 · 2025-09-23

Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate CancerNCT06612047 · 2024-10-08

Targeted And Perilesional Or Systematic Biopsy In Prostate CancerNCT07296042 · 2026-10-01

NOT_YET_RECRUITING

Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCaNCT07352748 · 2024-10-17

ACTIVE_NOT_RECRUITING

Characterization of Microbiological and Genetic Features in Prostate Cancer and Their Association with Disease StageNCT06505356 · 2024-09-01

ENROLLING_BY_INVITATION

Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer DetectionNCT06183905 · 2023-12-29

ACTIVE_NOT_RECRUITING

The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate CancerNCT05822726 · 2022-10-01

The TRANSLATE TrialNCT05179694 · 2021-12-03

Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer DetectionNCT04124107 · 2019-12-01

Optimizing the Number of Systematic COres During a MRI Target BiopsyNCT04183699 · 2019-06-06

The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.NCT03857477 · 2019-03-14

ACTIVE_NOT_RECRUITING

Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided BiopsyNCT04064047 · 2016-12-01

The BARCODE 1 Pilot StudyNCT03158922 · 2016-04-29

ACTIVE_NOT_RECRUITING

Assessment of Prostate MRI Before Prostate BiopsiesNCT02485379 · 2015-07-01

A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate CancerNCT01858688 · 2013-09-01

Common conditions

Prostate Cancer11 Metastatic Prostate Cancer1 p2PSA1 Pain1 Prostate Biopsy1 Prostate Cancer (Diagnosis)1 Prostate Inflammation1 Prostate Neoplasm1 PSMA1 Rectal/Anal1 Suspicion of Prostate Cancer With a Positive Multiparametric Magnetic Resonance of the Prostate1

Leading sponsors

Institute of Cancer Research, United Kingdom2 Anhui Provincial Hospital1 Assaf-Harofeh Medical Center1 Dana-Farber Cancer Institute1 Edgaras Burzinskis1 GCS Ramsay Santé pour l'Enseignement et la Recherche1 Hospices Civils de Lyon1 IRCCS San Raffaele1 Johns Hopkins University1 Ruijin Hospital1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Universita di Verona1 University of Oxford1 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine1

Trial status mix

ACTIVE_NOT_RECRUITING4

COMPLETED3

UNKNOWN3

RECRUITING2

ENROLLING_BY_INVITATION1

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

NA10

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.